BioDuro-Sundia

Trending Articles

  1. FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with...
  2. Miltenyi Biotec and CHA Biotech collaborate on BaEV lentiviral vector platform The pair will work to enhance CAR NK cell therapy manufacturing efficiency, combining Miltenyi Bioindustry's baboon envelope lentiviral vector platform with CHA Biotech's NK...
  3. Epitopea receives MHRA approval for first-in-human trial of RNA vaccine for ovarian cancer The company has received regulatory approval from the MHRA and Regional Ethics Committee to initiate its OVACT Phase I/Ib clinical trial of CryptiVax-1001, an off-the-shelf...
  4. Gerresheimer and Milliken partner to advance performance and protection with LeneX UltraGuard technology Up to 40% moisture barrier improvement in HDPE packaging. Enhanced performance, protection, and processing efficiency for demanding pharmaceutical applications
  5. FDA approves AstraZeneca's Saphnelo Pen autoinjector in systemic lupus erythematosus AstraZeneca has received FDA approval for a once-weekly subcutaneous autoinjector formulation of Saphnelo for systemic lupus erythematosus, offering patients a more convenient...

Upcoming event

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK See all

Related Content

Research & Development

BioDuro and CTI Technology partner to push forward preclinical drug development

The duo will combine their manufacturing experience and analytical capabilities to build an integrated platform spanning all the way from drug discovery to IND submission to accelerate the drug development path for clients
Research & Development

BioDuro appoints Dr. Andrew Thomas and Dr. Stevan Djuric as Scientific Advisors

Industry leaders bring decades of pharmaceutical R&D leadership to support BioDuro’s global innovation and clients’ programs
Manufacturing

BioDuro and Cenra form joint venture to boost global API manufacturing

The partnership will expand commercial-scale API production in Taipei, strengthening global supply chain resilience and offering integrated development-to-commercial manufacturing services
Sustainability

BioDuro sites recognised with EcoVadis Gold and Silver sustainability certifications

Three of the CDMO's Chinese sites have been recognised for outstanding sustainability performance, highlighting BioDuro’s commitment to sustainability and its ongoing efforts to embed environmental and social responsibility into its business operations
Manufacturing

BioDuro launches dedicated peptide unit to boost global peptide drug discovery and GLP-1 development

The new business unit unifies BioDuro’s chemistry, biology, DMPK and manufacturing capabilities, accelerating end-to-end peptide therapeutic development for global biopharma partners
Pharmaceutical

BioDuro appoints Yaohui Ji as Global President, CMC to accelerate expansion of integrated CRDMO capabilities

BioDuro, a trusted global Contract Research, Development, and Manufacturing Organization (CRDMO), announced the appointment of Mr. Yaohui Ji as Global President, CMC

Christopher Conway joins BioDuro board

Appointment strengthens strategic leadership for global CRDMO
Subscribe now